← Back to headlines
Novo Nordisk Sues Eli Lilly Over GLP-1 Advertising Claims
Novo Nordisk has filed a lawsuit against Eli Lilly, alleging misleading advertising claims related to GLP-1 medications.
21 Jul, 13:50 — 21 Jul, 13:50
Sources
Showing 1 of 1 sources
Related Stories
NATO Warns of Escalating Russian Gray Zone Attacks Across Europe
34m ago
Trump Administration Announces Major Oil Deal to Replenish U.S. Strategic Reserve
40m ago
Investors Eye Jobs Data and Major Earnings Reports for Market Direction
54m ago
North Korea Replaces Defense Minister in Military Shake-Up
2h ago